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INTRODUCTION 
 
Parkinson’s disease (PD) is a progressive, irreversible 
neurodegenerative condition which affects over 6 
million people across the globe [1]. The greatest risk 
factor for PD is advancing age, and with the number of 
people over the age of 60 expected to exceed 2 billion 
by the year 2050 (currently estimated to be over 900 
million) there will soon be significantly higher numbers 
of people living with PD [2]. The classical physical 
symptoms are known to be resting tremor, rigidity and 
bradykinesia. It is now also known that symptoms of 
PD include reduced quality of sleep as well as both 
cognitive impairments and poor mental health. In terms 
of the pathophysiology of the disease, the death of 
pigmented dopaminergic neurons in the substantia nigra 
pars compacta in PD patients is critical [3]. Molecular 
characteristics of PD include the aggregation of α-
synuclein leading to Lewy body formation, alongside 
mitochondrial dysfunction [4, 5]. 
 
Hereditary forms of PD can be either autosomal 
dominant or autosomal recessive, dependent upon the 
mutant gene involved. In both dominant and recessive 
forms of hereditary PD, autophagic and lysosomal 
pathways are both mechanistically implicated [6–8]. 
One of the critical pathways which has been linked to 
the onset of juvenile/early onset PD is the PINK1/ 
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One of the genes which has been linked to the onset of juvenile/early onset Parkinson’s disease (PD) is PINK1. 
There is evidence that supports the therapeutic potential of exercise in the alleviation of PD symptoms. It is 
possible that exercise may enhance synaptic plasticity, protect against neuro-inflammation and modulate L-
Dopa regulated signalling pathways. We explored the effects of exercise on Pink1 deficient Drosophila 
melanogaster which undergo neurodegeneration and muscle degeneration. We used a ‘power-tower’ type 
exercise platform to deliver exercise activity to Pink1- and age matched wild-type Drosophila. Mitochondrial 
proteomic profiles responding to exercise were obtained. Of the 516 proteins identified, 105 proteins had 
different levels between Pink1- and wild-type non-exercised Drosophila. Gene ontology enrichment analysis 
and STRING network analysis highlighted proteins and pathways with altered expression within the 
mitochondrial proteome. Comparison of the Pink1- exercised proteome to wild-type proteomes showed that 
exercising the Pink1- Drosophila caused their proteomic profile to return towards wild-type levels. 
www.aging-us.com 2 AGING 
Parkin mitophagy pathway, a form of autophagy for the 
degradation of dysfunctional mitochondria. The role of 
mitophagy is to provide a quality control mechanism for 
the mitochondrial population within a cell, and this is a 
particularly crucial function in energetically demanding 
neuronal cells [9]. 
 
Mechanistically, PINK1 localizes with outer 
mitochondrial membrane (OMM) of depolarized 
mitochondria and then recruits and activates the E3 
ubiquitin-ligase activity of Parkin via phosphorylation 
of its Ser65 residue [10, 11]. PINK1 has also been 
shown to phosphorylate the Ser65 residue of 
Ubiquitin, which aids in the activation of Parkin’s E3 
ligase activity [12, 13]. Ultimately these events lead to 
the ubiquitination of OMM proteins by Parkin, the 
autophagic machinery then degrades the ubiquitinated 
mitochondria [14]. Mutations in PINK1 (and Parkin) 
can result in autosomal recessive juvenile onset  
PD, with onset before the age of 40 years old [15]. 
While this form of PD is rare, a comprehensive 
understanding of it can improve the outcomes of 
patients with PINK1 mutations and also those with 
idiopathic PD due to their shared pathophysiology 
[16]. A recent publication by Sliter et al. reported that 
Pink1 and Parkin mitigate STING induced 
inflammation, where both Pink1-/- and Prkn-/- mice 
under exhaustive exercise have a strong inflammatory 
phenotype that is rescued by the concurrent loss  
of the STING pathway [17]. In the same year, Zhong 
et al. reported that newly synthesised oxidised 
mitochondrial DNA is exported to the cytosol and 
stimulates another of the innate immune responses, the 
NLRP3 inflammasome [18]. 
 
Given the overlapping biology between PINK1 loss of 
function in PD and other forms of genetic and sporadic 
PD, PINK1 null mutants of animal models are hugely 
useful in studies of PD. Pink1 loss of function 
Drosophila models were first developed in 2006, shortly 
after the first parkin loss of function mutant Drosophila 
models were being utilised in research [19–21]. These 
first studies found that Pink1 loss of function resulted in 
mitochondrial dysfunction, compromised fertility in 
males, indirect flight muscle degeneration and associated 
locomotor defects, increased sensitivity to oxidative 
stress, and dopaminergic degeneration (Park et al., 2006) 
[19]. Parkin overexpression rescued many of the defects 
observed in the Pink1 mutants, indicating the 
downstream function of Parkin in the now established 
PINK1/Parkin mitophagy pathway, reviewed here [22]. 
More recent studies using Pink1 mutant Drosophila have 
found that their neurons exhibit decreased levels of 
synaptic transmission, defective fission and reduced ATP 
levels due to decreased COXI and COXIV activity as 
well as non-motor symptoms such as learning and 
memory deficits, weakened circadian rhythms and 
electrophysiological changes in clock-neurons [23–25]. 
 
It was first observed in 1992 that participation in 
exercise reduced the risk of the onset of PD in later 
years, while later data showed that this protection against 
PD risk is more obvious in males [26, 27]. Many groups 
have presented data that show the therapeutic potential 
of exercise in the alleviation of patient symptoms  
[28–30]. The biochemical mechanisms that would 
explain these observations are still unclear, but current 
evidence suggests that exercise may enhance synaptic 
plasticity, protect against neuroinflammation and 
modulate L-Dopa regulated signalling pathways [31–33]. 
 
In this study we aimed to analyse the biochemical 
changes induced by exercise in the mitochondrial 
proteome of the Pink1 loss of function mutant (Pink1-) 
Drosophila. As exercise is reported to both reduce the 
risk of onset and improve outcomes for Parkinson’s 
disease patients, we sought to characterise the 
biochemical changes that could underpin this 
improvement in our model of Parkinson’s disease. We 
focused on the mitochondria as their dysfunction is 
widely associated with Parkinson’s disease, and the 
Pink1- genetic model has a disrupted mitophagy 
pathway due to the absence of a functional PINK1 
protein. 
 




Fly stocks were kindly provided to NM by Miguel 
Martins (MRC Toxicology Unit) and Alex Whitworth 
(MRC Mitochondrial Biology Unit). Fly stocks and 
crosses were maintained on standard cornmeal agar 
media at 25° C in a 12:12 light-dark cycle. The 
experiments were performed on males: wild type 




Approximately twenty wild-type control or Pink1- 
Drosophila, 1-4 days post-eclosion, were separated into 
glass vials filled with 5ml food. Exercised group vials 
were stoppered with cotton wool 6cm from the food; 
non-exercised group vials were stopped with cotton 
wool 1cm from the food, creating a physical barrier to 
activity. Both exercised and non-exercised groups were 
placed in racks on the ICE machine (Supplementary 
Material) for 30 minutes per day for 7 days. The 
Drosophila were exercised in the morning each day and 
were sacrificed by freezing at -80° C one hour after the 
final exercise bout. Comparison groups were exercised 
and non-exercised wild-type and Pink1- Drosophila. 
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Mitochondrial isolation 
 
Groups of twenty wild-type or Pink1- Drosophila were 
homogenised in 100-200µl mitochondrial extraction 
buffer (50mM Tris-Cl pH 7.4, 100mM KCL, 1.5mM 
MgCl2, 1mM EGTA, 50mM HEPES and 100mM 
sucrose) by 5 minutes of manual homogenisation using 
a 1.2-2ml Eppendorf micro-pestle (Sigma-Aldrich). The 
homogenate was centrifuged at 800g for 10 minutes, at 
4° C, to remove the insoluble fraction. Supernatants 
from the first centrifugation were centrifuged at 1,000g 
for 10 minutes at 4° C to pellet the nuclear fraction. 
Supernatants from the second centrifugation were 
centrifuged at 13,200g for 30 minutes at 4° C to pellet 
the mitochondrial fraction. The protein content was 
determined by Bradford assay (µg/µl) and 




50µg of the mitochondrial fraction were added to 
rehydration solution (8M urea, 2% CHAPS, 2% IPG 
Buffer, 0.1% bromophenol blue). 20mM DTT was 
added to an aliquot of rehydration solution directly 
before use. The standard protocol according to 
manufacturer instructions was followed [34]. Briefly, 
sample was applied to rehydrate ZOOM IPG strips for 
an hour at room temperature followed by iso-electric 
focusing using the ZOOM IPG (Life Technologies) 
system and pH 3-10 (non-linear) ZOOM IPG strips. 
Gels were stained (SimplyBlue™ SafeStain, Life 
Technologies) and imaged (ImageQuant 300, GE 
Healthcare Life Sciences). Analyses were performed 
using SameSpots software (Totallab) (one-way 
ANOVA). Three pooled biological replicates were 
included for each of the four groups. 
 
Samples were analysed by the Centre of Excellence in 
Mass Spectrometry at University of York [35]. Briefly, 
proteins were reduced and alkylated, followed by 
digestion in-gel with trypsin. Matrix Assisted Laser 
Desorption Ionization Tandem Time-of-Flight mass 
spectrometry (MALDI-TOF/MS) was used to analyse 
the samples. The generated tandem MS data was 
compared against the NCBI database using the 
MASCOT search programme to identify the proteins. 
De novo sequence interpretation for individual peptides 




30µg/µl of each mitochondrial fraction was prepared 
with 4X LDS sample buffer and 4mM DTT. Samples 
were run in triplicate on a 4-12% Bis-Tris gel in 1X 
MES SDS running buffer for 40 minutes at 200V (all 
Invitrogen). Three biological replicates were run for 
each of the four groups. The whole, individual gel lanes 
were excised and placed into separate Eppendorf tubes. 
 
Samples were analysed by the Centre of Excellence in 
Mass Spectrometry at University of York [35]. Briefly, 
protein was in-gel digested post-reduction and 
alkylation. The resulting extracted peptides were 
analysed over 1-hour LC-MS acquisitions with elution 
from a 50cm, C18 PepMap column onto a Thermo 
Orbitrap Fusion Tribrid mass spectrometer using a 
Waters mClass UPLC. Extracted tandem mass spectra 
were searched against the combined Drosophila 
melanogaster and Saccharomyces cerevisiae subsets of 
the UniProt database. Protein identifications were 
filtered to achieve <1% false discovery rate as assessed 
against a reverse database. Identifications were further 
filtered to require a minimum of two unique peptides 
per protein group. 
 
For relative label-free quantification, extracted ion 
chromatograms for identified peptides were extracted 
and integrated for all samples. A maximum mass 
deviation of 3 ppm and retention time drift of 3 mins 
were set. Resulting quantifications were further filtered 
to an arbitrary PEAKS quality factor of 5 for feature 
mapping and required a minimum of two aligned 
features from a minimum of two unique peptides per 
protein quantification. Protein abundances were 
normalised between samples based on total identified 
peptide ion area. 
 
Gene ontology enrichment analysis 
 
gProfiler was used to undertake Gene Ontology (GO) 
enrichment analysis for the label-free mass 
spectrometry identified proteins with significant 
expression differences between each of the four 
experimental groups [36]. KEGG, Molecular Function 
(MF), Biological Process (BP) and Cellular 
Compartment (CC) enrichment analyses are generated 
by gProfiler are presented.  
 
Protein-protein interaction network analysis 
 
Differences in expression of proteins between groups 
were further analysed using the STRING database 
v.11.0 [37]. The platform was used to create protein-
protein interaction (PPI) networks based upon the 
differentially expressed proteins (DEPs) observed 
between groups. 
 
RESULTS AND DISCUSSION 
 
We subjected male Pink1- and wild-type Drosophila to a 
seven-day exercise regimen, whilst maintaining groups of 
unexercised Pink1- and wild-type as controls. The 
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mitochondria of the four groups were then isolated and 
investigated using 2D gel electrophoresis and label-free 
mass spectrometry analyses to determine changes in their 
mitochondrial proteome. The 2D gel electrophoresis 
method allowed for a fast and simple separation of 
proteins, which served as a scoping method to identify 
some of the most significant changes in expression. 
Label-free mass spectrometry analyses generated 
proteomes that we used in network enrichment analysis. 
Previously we have used proteomic profiling to 
characterise mitochondrial populations in both mice and 
long-lived pipistrelle bats, and here we apply this to 
better understand the PD phenotype as well as possible 
changes due to exercise [38, 39]. 
 
2DE-MS identified a general reduction in protein 
expression post-exercise in the Pink1 mutant 
Drosophila 
 
We isolated mitochondria from exercised and non-
exercised Pink1- Drosophila and performed 2DE-MS on 
these fractions (Supplementary Figure 1). All proteins 
that were identified as changed in expression after the 
exercise intervention were reduced in expression (Table 
1). PINK1 is recognised as having a central role in 
mitophagy, ensuring a healthy pool of mitochondria are 
maintained [19, 20]. It has recently been recognised that 
the regulation of mitophagy by the PINK1 system is 
age-dependent, with the Drosophila dependency on this 
pathway increasing with age [40]. Further, it has also 
been reported that earlier in the lifespan of the 
Drosophila there is a basal level of mitophagy that is 
not disrupted by the loss of PINK1 [41]. 
 
It is therefore possible that alternate mitophagy 
pathways can compensate for the loss of PINK1 and are 
upregulated during exercise, and this could account for 
the sweeping reductions in protein levels via 2DE-MS 
(Table 1). Indeed, alternative proteins have been 
identified and a pathway described in which they 
promote PINK1/PARKIN-independent mitophagy: 
AMBRA1, HUWE1 and IKKα [42]. It is also notable 
that ATG8, the final mediator of the AMBRA1 
PINK1/PARKIN-independent mitophagy pathway, has 
been reported to be upregulated in response to exercise 
as a part of a broader upregulated autophagic response 
to exercise [43]. However, it could also be suggested 
that the energetic demands of the exercise result in less 
energy available to protein synthesis pathways. In this 
instance, exercise would likely affect proteostasis more 
broadly, beyond just the mitochondrial proteome. 
 
The specific proteins identified within the table include 
structural proteins such as tropomyosin which is 
associated with the intracellular transport of mitochondria 
as well as mitochondrial metabolic proteins from a 
variety of pathways, such as acyl co-enzyme A 
dehydrogenase from the β-oxidation pathway, isocitrate 
dehydrogenase from the TCA cycle, and the metabolic 
gatekeeper pyruvate dehydrogenase. Due to the varied 
function of the proteins in Table 1, it is likely that their 
downregulation is representative of a broader decrease in 
protein expression levels in Pink1 Drosophila in response 
to exercise. 
 
We proceeded to pursue the directionally homologous 
2DE-MS results by obtaining a global topology of the 
mitochondrial protein changes that occur to Pink1- 
Drosophila due to exercise intervention using a label-
free proteomics method. 
 
GO annotation of identified label-free proteins and 
proportion identified that are localised to 
mitochondria 
 
Non-gel-based label-free proteomic analyses identified 
516 proteins from the mitochondrial fractions of Pink1- 
and wild-type Drosophila (Supplementary Table 1). GO 
and KEGG analyses showed that these fractions were 
enriched for mitochondrial processes and pathways, 
confirming the efficacy of our fractionation 
methodology (Figure 1). The top term of the GO 
cellular compartment analysis was cytoplasm, followed 
by mitochondrion and sub-mitochondrial compartments, 
many mitochondrial proteins are known to also localise 
to the cytoplasm [44, 45]. 
 
Pink1- Drosophila have decreased levels of proteins 
from energy metabolism pathways compared with 
wild-type Drosophila 
 
Label-free proteomics highlighted 105 differently 
expressed proteins between non-exercised wild-type 
Drosophila and non-exercised Pink1- Drosophila 
(Supplementary Table 2). Ten of the proteins were 
shown to be reduced in expression in Pink1- Drosophila 
compared to wild-type Drosophila. We found that 
Pink1- Drosophila have reductions in protein expression 
in proteins from mitochondrial processes associated 
with energy metabolism, with the top GO biological 
process terms being oxidative phosphorylation, electron 
transport chain, ATP metabolic process and oxidation-
reduction process (Figure 2). 
 
The deficiencies in mitochondrial oxidative 
phosphorylation, the electron transport chain and 
specifically in the activity of Complex I in Parkinson’s 
disease are well established, and this aligns with our 
findings from the GO analysis of the proteomics data 
[46–49]. Specific subunits of complexes within the 
electron transport chain that decreased in expression 
include NADH dehydrogenase (ubiquinone) 75 kDa 
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Table 1. Expression changes between exercised Pink1- Drosophila and non-exercised Pink1- Drosophila. 
Pink1- mitochondria - 2DE    
Protein identity ANOVA (p) Fold change Exercise related change 
Tropomyosin-1, isoforms 33/34 
0.022 1.4 ↓ 
Tropomyosin-2 
Acyl-coenzyme A dehydrogenase 0.015 1.4 ↓ 
Isocitrate dehydrogenase 0.008 1.4 ↓ 
Enolase 0.022 1.3 ↓ 
Probable isocitrate dehydrogenase [NAD] subunit alpha 
0.015 1.5 ↓ Glycerol-3-phosphate dehydrogenase [NAD(+)] 
Pyruvate dehydrogenase E1 component subunit beta 
Pyruvate dehydrogenase E1 component subunit beta 
0.048 1.3 ↓ 
Aldo-keto reductase, isoform C 
Alcohol dehydrogenase 
0.024 1.3 ↓ 
CG9992, isoform A 
Changes in expression were determined by 2DE-MS. 
 
subunit isoform B (complex I), GH01077p (complex III 
in Drosophila), HDC00331 (complex IV in Drosophila) 
and Levy isoform A (complex IV in Drosophila). While 
complex I and complex IV have been reported as 
dysfunctional in PD, reduced expression or decreased 
activity for complex III isn’t well documented [47, 50, 
51]. However, decreased Complex II/III activity has 
been shown in platelets of untreated Parkinson’s disease 
patients [52]. 
 
It is interesting to note that most (95/105) of the 
differentially expressed proteins were more highly 
expressed in Pink1- Drosophila (Supplementary Table 
2). GO biological process analysis showed these 
proteins to be enriched for redox processes, cytoplasmic 
translation, cellular amide metabolic processes and fatty 
acid derivative biosynthetic processes. GO cellular 
compartment analysis showed that the more highly 
expressed proteins in Pink1- were enriched for 
cytoplasmic ribosomes, organelle membranes and 
endoplasmic reticulum. KEGG pathway analysis 
paralleled these findings, highlighting the identified 
proteins as involved in fatty acid metabolism, ribosomes 
and one carbon pool by folate. 
 
There is evidence linking fatty acid metabolism and 
function to Parkinson’s disease, with proteins identified 
by GWAS studies, suppressed β-oxidation, and physical 
interaction between α-synuclein and fatty acids potential 
being key factors [53–57]. Early studies into the effect 
of α-synuclein (SNCA) gene deletion on lipid 
metabolism in mice reported reduced palmate uptake 
and altered palmate metabolism in the brain, reduced 
acyl-CoA Synthetase activity that resulted in reduced 
arachidonic acid uptake and turnover, and increased 
docosahexaenoic acid brain mass, incorporation and 
turnover [58–60]. Our own work shows differences in 
arachidonic acid derivatives in Parkinson’s disease 
mitochondria [61]. 
 
The data presented here show an enrichment of the 
folate metabolic pathway, not reported previously. It 
may be that in Pink1- Drosophila this is a compensatory 
mechanism. KEGG analysis highlighted the metabolism 
of folate (vitamin B9) as enriched in Pink1
- Drosophila. 
B-vitamins, in particular folate, are well studied in the 
context of Parkinson’s disease due to the observation of 
homocysteine (a methionine cycle metabolite) having 
neurotoxic effects [62–65]. It is hypothesised that the 
administration of B-vitamins can drive the synthesis of 
methionine, thus reducing intracellular homocysteine 
[66–68]. However, the relationship between B -
vitamins, neurotoxicity and Parkinson’s disease is 
complex and a consensus has yet to be established. 
Some data show either little correlation between 
homocysteine levels and B vitamins including B6, 
folate and B12 while others show contradictory results, 
including elevated homocysteine levels and decreased 
folate levels in Parkinson’s disease patients [68–71]. 
 
Exercise reduces measured protein levels in Pink1- 
Drosophila 
 
The 2DE-MS analysis of exercised and non-exercised 
Pink1- Drosophila revealed reductions in twelve proteins 
in response to exercise (Table 1). Label-free proteomics 
showed a similar pattern in Pink1- exercised Drosophila 
compared with non-exercised Pink1- Drosophila; of  
the fifty-seven protein expression differences, fifty-five 
were reductions of protein expression in response to 
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Figure 1. Enrichment analysis of all proteins identified by label-free proteomics. Biological process, cellular compartment and 
KEGG enrichment analysis each presented processes associated with mitochondrial function and physiology. 
www.aging-us.com 7 AGING 
exercise (Supplementary Table 3). GO:MF and KEGG 
pathway analysis determined that the terms ribosomal 
and fatty acid metabolism were significantly 
represented in the proteins with reduced expression 
(Figure 3). Interestingly, these terms were shown to be 
increased in Pink1- Drosophila compared to wild-type 
Drosophila that had not been exercised. This suggests 
that in Pink1- Drosophila exercise returns levels of 
protein expression towards wild-type values. 
 
It has been shown that PINK1 interacts with the 
protein translation pathway and that increased  
protein translation in Pink1- Drosophila causes an 
exacerbated Pink1- phenotype. Taking this a step 
further, it was shown that 40S ribosomal subunit S6 
(RpS6) RNAi was able to mitigate the Pink1- 
phenotype [72]. These data suggest improper protein 
translation regulation is involved in the pathogenesis 
of PD and that inhibition of this pathway mitigates 
progression. Exercise appears to be able to reverse the 
upregulated protein translation pathways found in 
Pink1- Drosophila. 
 
KEGG analysis identified fatty acid metabolism from 
proteins reduced in expression due to exercise, while 
GO:MF analysis highlighted CoA Carboxylase activity 
from the same protein data set. This reduction in the 
metabolism, and in particular the synthesis, of fatty 
acids can be contrasted with the KEGG analysis 
described earlier which identified elevated expression of 
fatty acid metabolism associated proteins in Pink1- 
Drosophila compared with wild-type Drosophila. It can 
be interpreted that exercise reverses the change in 
Pink1- Drosophila and returns the fatty acid metabolic 
profile back towards wild-type Drosophila. 
 
The two proteins upregulated with exercise in Pink1- 
Drosophila were OCIA domain-containing protein 1 
(OCIAD1) and dihydroorotate dehydrogenase (quinone) 
mitochondrial (DHODH), neither have previously been 
connected with exercise. OCIAD1 has been shown to 
localise to both endosomes and mitochondria and 
regulate pathways such as JAK/STAT, Notch and 
PI3K/AKT [73–75]. OCIAD1 has been shown to 
regulate mitochondrial ETC activity via control of 
complex I activity, which showed an inverse association 
with OCIAD1 overexpression [76]. Deregulated 
OCIAD1 levels have been linked to mitochondrial 
dysfunction, interaction with BCL-2 and Alzheimer’s 
disease [75]. 
 
DHODH is an inner mitochondrial membrane enzyme 
that catalyses the fourth step in de novo synthesis of 
pyrimidines [77]. A link between pyrimidine synthesis 
and mitochondrial morphology was shown with the 
addition of the drug leflunomide to muscle cells [78]. 
The group showed that leflunomide inhibited DHODH 
by binding to its ubiquinone binding channel, thereby 
preventing the production of pyrimidine ribonucleotide 
uridine monophosphate (UMP). DHODH inhibition 
induced upregulation of mitochondrial fusion and 
subsequent mitochondrial elongation, by depleting the 
cellular pyrimidine pool. As ubiquinone is reduced to 
ubiquinol in the DHODH-mediated catalysis of 
dihydroorotate to orotate, and as ubiquinol is a substrate 




Figure 2. GO: Biological process analysis for downregulated protein expression differences between Pink1 non-exercised and 
wild-type non-exercised files. Pink1 files have reduced expression of proteins involved in mitochondrial respiration and oxidative 
phosphorylation. 
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ETS. DHODH deficiency has been reported to partially 
inhibit complex III and increase ROS generation [79]. 
 
The same Pink1- Drosophila strain has previously  
been reported to have upregulated genes involved in 
nucleotide metabolism, which is also the case in brains of 
PD patients with PINK1 mutations [80]. Genetic and 
pharmacological upregulation of nucleotide metabolism 
and scavenging pathways restored mitochondrial function 
caused by PINK1 loss. Therefore, DHODH upregulation 
by exercise may act in a compensatory manner to manage 




Figure 3. GO: Molecular Function and KEGG analysis for proteins reduced in expression in Pink1- exercised files compared 
with Pink1- non-exercised files. Both Molecular Function and KEGG enrichment analysis indicated a decrease in expression of fatty acid 
metabolic proteins in the exercised Pink1- files. 
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Exercise reduces the difference in levels of protein 
expression between Pink1- and wild-type drosophila 
 
Of the 516 proteins identified, 105 protein had different 
levels between non-exercised Pink1- Drosophila and 
non-exercised wild-type Drosophila (Supplementary 
Table 2). Comparing the exercised Pink1- Drosophila 
group to either non-exercised wild-type Drosophila, or 
exercised wild-type Drosophila, showed close to half 
the number of differentially expressed proteins (55 and 
56 proteins, respectively) (Supplementary Tables 4, 5). 
Qualitatively the heatmap of protein expression for 
exercised Pink1- Drosophila more closely resembles 
wild-type Drosophila (Figure 4). This suggests exercise 
can ameliorate the aberrant protein profile of Pink1- 
Drosophila towards a more wild-type profile. 
 
This is in agreement with findings from Cheedipudi  
et al. (2020) who reported gene expression data  
from an exercised mouse model of arrhythmogenic 
cardiomyopathy, that originally showed a dysregulation 
of near 800 genes, showed partial restoration of gene 
expression with regular exercise, with the greatest 
remedial effects on proteins involved in inflammation 
and oxidative phosphorylation [81]. 
 
Network analyses of differentially expressed proteins 
 
STRING database network analysis complemented  
the results seen with gProfiler. The protein-protein 
interaction (PPI) networks were generated using 
STRING, and Figure 5A shows that exercised Pink1- 
Drosophila, compared with the exercised wild-type 
Drosophila, have a differentially expressed proteins 
(DEPs) network that consisted of 49 nodes and 200 
edges with average node degree 8.16 and PPI 
enrichment p-value of (P < 1.0e-16). 
 
Most of the proteins in the network have downregulated 
expression, with the following proteins found to be 
upregulated: endoplasmic reticulum chaperone BiP, 
enoyl-CoA hydratase short chain, glutamine synthetase, 
protein disulfide isomerase, methylmalonate-
semialdehyde dehydrogenase, polyadenylate-binding 
protein, poly(U)-specific endoribonuclease, glutamine 
synthetase, flotillin-1, heat shock protein 22, 
phosphatidate cytidylyltransferase, fatty acyl-CoA 
reductase and dihydroorotate dehydrogenase. 
 
The DEPs were found to be part of the ETC and 
OXPHOS processes, transmembrane transport and 
oxidative-reduction processes. The highly connected 
cluster in this network consisted of proteins from 
complex I: ND-18, ND-MLRQ, ND-ASHI, ND-
B14.5B, ND-B14, ND-B16.6, ND-49, ND-51, ND-
B17.2, ND-B14.7; complex IV: COX6B, COX4, mt: 
COII, COX5A; complex III: OX, and other proteins 
CYPE, UQCR-6.4, UQCR-14, levy and 40S ribosomal 
proteins S18. This cluster of proteins was downregulated 
in the exercised Pink1- Drosophila. 
 
Figure 5B shows the non-exercised Pink1- Drosophila 
versus the non-exercised wild-type Drosophila PPI 
network, which consists of 86 nodes and 121 edges with 
average node degree 2.81 and PPI enrichment p-value (P 
< 1.0e-16). In contrast to exercised Pink1- Drosophila 
versus exercised wild-type Drosophila, all DEPs were 
upregulated, except for cytochrome c oxidase subunit 4, 
cyclope isoform A, flightin isoform B, cytochrome b-c1 
complex subunit 7, NADH dehydrogenase 1 alpha 
subcomplex 12, Troponin 1, NADH dehydrogenase 18, 
cytochrome c oxidase subunit, cytochrome P450, NADH 
dehydrogenase 1 beta subcomplex subunit 8, cytochrome 
c oxidase subunit 5A, NADH dehydrogenase B14 and 
levy isoform A. 
 
The DEPs were found to be a part of oxidation-reduction 
processes, fatty-acyl-CoA metabolic processes, 
translation and protein folding. The identification of 
DEPs from fatty-acyl-CoA metabolic process is 
concurrent with the enrichment analysis presented in 
Figure 3. The highly connected node in this network is 
that of upregulated ribosomal proteins RPS18, RPS23, 
RPS23, RPS7, RPS14b, RPL6, RPL5, RPL10AB and 
RPL9. 
 
The DEPs were found to be a part of oxidation-reduction 
processes, fatty-acyl-CoA metabolic processes, 
translation and protein folding. The identification of 
DEPs from fatty-acyl-CoA metabolic process concurs 
with the enrichment analysis presented in Figure 3. The 
highly connected node in this network is that of 
upregulated ribosomal proteins RPS18, RPS23,  
RPS23, RPS7, RPS14b, RPL6, RPL5, RPL10AB and 
RPL9. 
 
Similarly, for Figure 6A–6C, three additional PPI 
networks were generated for DEPs in pairwise group 
comparisons. For exercised Pink1- Drosophila 
compared with non-exercised Pink1- Drosophila the PPI 
network consisted of 43 nodes and 29 edges with 
average node degree 1.35 and PPI enrichment p-value 
<1.62e-06 (Figure 6A). All of the DEPs were 
downregulated except for OCIA domain containing 
protein 1 and dihydroorotate dehydrogenase. The DEPs 
were found to be involved in formation of 40S 
ribosomal subunit, oxidation reduction processes, 
synthesis of ketone bodies, translation and cellular lipid 
catabolic processes. 
 
For non-exercised Pink1- Drosophila compared with 
exercised wild-type Drosophila the network has 107 
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nodes and 341 edges with average node degree 6.37 and 
PPI enrichment p-value (P <1.0e-16) (Figure 6B). The 
DEPs were found to be involved in ETC, translation, 
peroxisome, formation of 40S subunits and protein 
folding. The PPI network showed three highly 
connected clusters. Cluster 1 contained proteins from 
both complex I and complex IV, proteins that are 
downregulated like that of exercised Pink1- Drosophila 
compared with the exercised wild-type Drosophila. 
Cluster 2 contained ribosomal proteins that are 
upregulated, similar to that of non-exercised Pink1- 
Drosophila compared with the non-exercised wild-type 
Drosophila PPI network. Cluster 3 contains the proteins 
UGT, HSP22, HSP60C, CABP1, GP93, HSC70-5, 
HSC70Cb, HSP60A, RTNL1 and CNX99A. These 
proteins involved in proteostasis and protein folding and 
were found to be upregulated. 
 
For the final PPI network, exercised Pink1- Drosophila 
compared with non-exercised wild-type Drosophila, 
there are 44 nodes and 40 edges with average node 
degree 1.82 and PPI enrichment p-value 6.79e-11 
(Figure 6C). The exercised Pink1- Drosophila versus 
non-exercised wild-type Drosophila were involved in 
purine ribonucleotide triphosphate metabolic processes, 




Figure 4. Heat map of protein expression levels (for proteins identified among all groups), determined by label-free mass 
spectrometry of mitochondrial fractions. Qualitatively, the identified Pink1- exercised fly proteome more closely resembles the two WT 
fly proteomes than does the Pink1 non-exercised fly proteome. 
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Figure 5. Network analysis of differentially expressed proteins. (A) Pink1- exercised vs wild type exercised; (B) Pink1- non-exercised vs 
wild type non-exercised. Networks analysed using STRINGdb. The nodes are coloured according to the processes (legend) that the proteins 
are involved in by using GO Terms for Biological Processes. The edge shows type of interactions, experimentally determined interactions are 
pink and those obtained from databases are sky blue. Predicted interactions such as gene neighbourhood are blue, green and red for gene 
co-occurrence, gene neighbourhood and gene fusions. Co-expression interactions are shown in black, text-mining interactions are shown in 




Figure 6. Network analysis of differentially expressed proteins. (A) Pink1- exercised vs Pink1- non-exercised; (B) Pink1- non-exercised 
vs wild type exercised; (C) Pink1- exercised vs wild type non-exercised. Networks analysed using STRINGdb. The nodes are coloured according 
to the processes (legend) that the proteins are involved in by using GO Terms for Biological Processes. The edge shows type of interactions, 
experimentally determined interactions are pink and the one obtained from databases are sky blue. Predicted interactions such as gene 
neighbourhood are blue, green and red for gene co-occurrence, gene neighbourhood and gene fusions. Co-expression interactions are shown 
in black, text-mining interactions are shown in light green and protein homology edges are purple. 
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For each of the three PPI networks, the number of edges 
is larger than expected and the nodes were more 





A picture of mitochondrial proteomic changes made in 
response to exercise was obtained by using two 
different mass spectrometry methodologies. We were 
able to measure changes in an organelle whose function 
in exercise, and dysfunction in Parkinson’s disease, is 
crucial. 
 
2D-GE MS data comparison between Pink1- exercised 
and Pink1- non-exercised Drosophila revealed several 
proteins with decreased levels of expression in response 
to exercise. These data were indicative of a generalised 
reduction of expression of the mitochondrial proteome 
in Pink1- Drosophila in response to exercise. This was 
investigated further in exercised and non-exercised 
Drosophila, both wild-type and Pink1-, by label-free 
mass spectrometry. 
 
GO and KEGG analyses of the label-free mass 
spectrometry proteomic data validated our mitochondrial 
isolation methodology by identifying the enrichment of 
mitochondrial processes and pathways. The comparison 
between non-exercised wild-type Drosophila and non-
exercised Pink1- Drosophila revealed that proteins 
involved in bioenergetics had reduced expression in  
the mutant. Most strikingly, exercise of the Pink1- 
Drosophila caused a broad reduction in protein 
expression within the mitochondrial protein, resulting in 
the Pink1- Drosophila mitochondrial proteome to return 
to levels similar to the wild-type Drosophila. 
 
GO, KEGG and STRING network analysis of the 
differentially expressed proteins from the mitochondrial 
proteome comparisons identified enrichment of 
bioenergetic pathways. The most significantly enriched 
pathways in the non-exercised Pink1- Drosophila 
included oxidation-reduction, fatty acid metabolism, 
and folate metabolism, all of which are associated with 
PD. Our data point to exercise aiding normalisation of 
these pathways. Specific proteins in the pathways may 
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SUPPLEMENTARY MATERIALS 
 
Ingram counter-balanced exerciser 
 
Our bespoke Ingram Counter-balanced Exercise (ICE) 
machine was adapted from the PT design of Piazza et 
al., by Mr. John Ingram (TI’s father) [82]. The exerciser 
fits into an incubator with internal dimensions of 48 x 
48 x 35cm and provides a vertically moving tray 
measuring 30 x 34cm. A solenoid-powered 
counterbalanced lever causes the tray to be lifted 3cm. 
The tray is lifted and immediately dropped every 15 
seconds. 
 
Counterbalancing the lever are a series of springs, 
which can be adjusted to allow lifts of up to 3.0kg. 
Springs efficiently store and release energy enabling a 
more rapid drop than would be the case if weights were 




Lift is provided by a solenoid wound onto a nylon core 
and fixed to the body of the exerciser. The steel 
armature passing through the solenoid is attached to the 
counterbalanced lever. Activation of the solenoid causes 
the armature to rise which lifts the lever. 
 
Solenoid activation is controlled by an astable timer. 
This triggers a relay to pulse the applied AC voltage. 
Two capacitors acting as a loss-less resistor allow the 
voltage to be reduced without producing excess heat, 
before it is rectified, smoothed and finally applied to the 
solenoid. Powering with DC current causes less 
vibration and heat generation in the solenoid but, as the 
capacitors and the solenoids both work more efficiently 
at lower temperatures, any excess heat is subsequently 
dissipated by proximate fans. Using a pulse of current 
as described rather than the discharge from a large 
capacitor to activate the solenoid saves space, it is also 
safer as there is far less stored energy. 





Supplementary Figure 1. Representative 2DE gels of (A) exercised Pink1, (B) non-exercised Pink1, (C) exercised wildtype, (D) non-exercised 
wildtype Drosophila melanogaster. 
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Supplementary Tables 
 
Please browse Full Text version to see the data of Supplementary Tables 1–5. 
 
Supplementary Table 1. Label-free MS identified 516 proteins from the mitochondrial fractions of Pink1- and 
WT D. melanogaster. 
 
Supplementary Table 2. Label-free MS identified 105 proteins with different abundance when comparing non-
exercised Pink1- and wildtype flies. 
 
Supplementary Table 3. Label-free MS identified 57 proteins with altered abundance between exercised and 
non-exercised Pink1- flies, 55 of which had decreased abundance. 
 
Supplementary Table 4. Label-free MS identified 56 proteins with different abundance when comparing 
exercised Pink1- and exercised WT flies. 
 
Supplementary Table 5. Label-free MS identified 55 proteins with different abundance when comparing 
exercised Pink1- and non-exercised WT flies. 
